Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Severstal does not rule out more than 100% FCF

3/13/24 CHMF

Drone attack on Lukoil refinery reduced its capacity by 50%

3/13/24 LKOH

Tinkoff Investments launches Pre-IPO platform

3/13/24 T

M.Video-Eldorado to open stores in new territories

3/13/24 MVID

Tinkoff Investments launches Pre-IPO platform

3/13/24 OTCI

Kamchatskenergo reported for 2023 by RAS

3/13/24 KCHE

Lukoil bought the mansion Blue Pearl

3/13/24 LKOH

Board of Directors of LESK recommended dividends

3/12/24 LPSB

Lukoil launches top management remuneration program

3/12/24 LKOH

Freedom.bi has opened an investment round

3/12/24 OTCI